SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | (Q1)Aug 31, 2023 | (FY)May 31, 2023 | (Q4)May 31, 2023 | (Q3)Feb 28, 2023 | (Q2)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -122.87%-35.31M | -490.91%-30.91M | -29.57%30.71M | 17.56%-15.36M | -204.11%-30.41M | 65.76%-15.84M | 104.46%7.91M | 312.42%43.6M | 59.84%-18.63M | 270.60%29.21M |
Net income from continuing operations | 37.97%-34.65M | 84.59%-222.4M | 87.17%-15.38M | 91.22%-104.98M | 25.07%-46.18M | 15.09%-55.86M | -232.39%-1.44B | 73.83%-119.82M | -2,378.71%-1.2B | -1,163.22%-61.64M |
Operating gains losses | -193.56%-6.8M | -45.88%25.59M | -17.18%14.24M | 36.16%9.39M | -195.54%-5.31M | -58.80%7.27M | 122.47%47.28M | 978.23%17.19M | 109.27%6.9M | 105.90%5.56M |
Depreciation and amortization | 3.33%31.81M | -2.49%126.91M | 9.44%31.73M | -2.75%32.84M | -5.30%31.55M | -9.63%30.79M | -15.81%130.15M | -28.88%28.99M | -8.78%33.77M | -11.08%33.32M |
Deferred tax | 547.46%382K | -21.65%-38.87M | -1,202.69%-31.47M | 79.77%-3.36M | 70.15%-4.1M | -92.59%59K | -16.03%-31.95M | 76.41%-2.42M | -173.50%-16.6M | -200.67%-13.74M |
Other non cash items | 131.85%3.8M | -79.05%54.98M | -93.60%4.33M | -65.23%64.08M | -118.21%-1.51M | -620.30%-11.92M | 632.82%262.44M | 419.44%67.57M | 649.72%184.29M | 87.64%8.29M |
Change In working capital | -759.97%-36.77M | -161.61%-8.87M | -52.64%20.01M | 28.36%-21.4M | -128.10%-13.06M | 112.53%5.57M | 115.69%14.4M | 365.73%42.25M | 4.27%-29.87M | 571.40%46.47M |
-Change in receivables | -117.95%-2.34M | -257.75%-6.58M | 12.47%-12.15M | -90.72%1.05M | -187.31%-8.52M | 525.16%13.04M | 171.35%4.17M | -157.89%-13.89M | 455.98%11.36M | -22.57%9.76M |
-Change in inventory | -439.26%-12.38M | -20.44%-15.58M | -872.38%-10.95M | 21.10%-13.3M | -4.91%5.02M | 1,673.28%3.65M | 71.73%-12.93M | 96.15%-1.13M | 15.40%-16.85M | 448.84%5.28M |
-Change in prepaid assets | -191.58%-13.57M | 318.61%13.07M | -66.70%11.92M | 89.49%-2.62M | -68.95%8.42M | 86.66%-4.65M | -30.19%3.12M | 559.94%35.8M | -565.77%-24.9M | 2,706.52%27.11M |
-Change in payables and accrued expense | -30.96%-8.47M | -98.94%212K | 45.34%31.19M | -1,352.30%-6.54M | -515.73%-17.98M | -3.26%-6.47M | 144.89%20.04M | 61.44%21.46M | 103.89%522K | 119.73%4.32M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -122.87%-35.31M | -490.91%-30.91M | -29.57%30.71M | 17.56%-15.36M | -204.11%-30.41M | 65.76%-15.84M | 104.46%7.91M | 312.42%43.6M | 59.84%-18.63M | 270.60%29.21M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -87.89%-49.4M | 145.02%128.35M | 694.09%45.06M | 711.63%28.09M | 130.03%81.5M | -1,610.47%-26.29M | -1,224.07%-285.11M | -54.30%-7.58M | -347.56%-4.59M | -3,792.69%-271.4M |
Net PPE purchase and sale | -76.06%-6.71M | -25.73%-20.74M | 76.97%-2.37M | -936.46%-8.73M | -51.98%-5.84M | -147.89%-3.81M | 24.53%-16.5M | -109.09%-10.28M | 37.72%-842K | 44.92%-3.84M |
Net business purchase and sale | --0 | -126.91%-60.63M | --0 | --0 | -242.94%-83.58M | --22.96M | -8,295.71%-26.72M | --1.4M | -1,250.31%-3.75M | ---24.37M |
Net investment purchase and sale | 6.05%-42.69M | 186.70%209.72M | 3,579.05%47.42M | --36.81M | 170.28%170.92M | ---45.44M | ---241.9M | --1.29M | --0 | ---243.19M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -87.89%-49.4M | 145.02%128.35M | 694.09%45.06M | 711.63%28.09M | 130.03%81.5M | -1,610.47%-26.29M | -1,224.07%-285.11M | -54.30%-7.58M | -347.56%-4.59M | -3,792.69%-271.4M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 332.23%60.59M | -207.17%-75.19M | 13.37%7.07M | -346.72%-10.91M | -49.10%-85.37M | -88.66%14.02M | -45.27%70.16M | -96.15%6.24M | 56.12%-2.44M | -186.01%-57.26M |
Net issuance payments of debt | -141.96%-5.88M | -43.88%-83.81M | -124.84%-1.55M | -346.72%-10.91M | -49.10%-85.37M | 393.02%14.02M | 52.85%-58.25M | 106.70%6.24M | 61.50%-2.44M | -255.80%-57.26M |
Net common stock issuance | --66.47M | -93.29%8.62M | --8.62M | --0 | --0 | --0 | -49.41%128.4M | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 332.23%60.59M | -207.17%-75.19M | 13.37%7.07M | -346.72%-10.91M | -49.10%-85.37M | -88.66%14.02M | -45.27%70.16M | -96.15%6.24M | 56.12%-2.44M | -186.01%-57.26M |
Net cash flow | ||||||||||
Beginning cash position | 10.51%228.34M | -50.32%206.63M | -11.36%146.25M | -23.80%144.95M | -63.49%179.13M | -50.32%206.63M | -14.85%415.91M | -40.91%165M | -42.67%190.22M | 30.39%490.64M |
Current changes in cash | 14.23%-24.11M | 110.75%22.26M | 96.05%82.83M | 107.08%1.82M | 88.55%-34.28M | -137.08%-28.11M | -193.27%-207.05M | -69.02%42.25M | 51.56%-25.67M | -578.83%-299.45M |
Effect of exchange rate changes | 56.03%958K | 75.38%-549K | -21.30%-746K | -215.06%-512K | 109.69%95K | 156.85%614K | -13.89%-2.23M | -288.65%-615K | 8.01%445K | -143.78%-980K |
End cash Position | 14.54%205.19M | 10.51%228.34M | 10.51%228.34M | -11.36%146.25M | -23.80%144.95M | -63.49%179.13M | -50.32%206.63M | -50.32%206.63M | -40.91%165M | -42.67%190.22M |
Free cash flow | -110.28%-42.04M | -366.53%-60.15M | -32.68%21M | -27.71%-24.89M | -247.00%-36.27M | 59.42%-19.99M | 93.90%-12.89M | 219.43%31.19M | 61.79%-19.49M | 200.04%24.67M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |